Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
27.47
-0.31 (-1.12%)
Oct 29, 2024, 4:00 PM EDT - Market closed

Denali Therapeutics Statistics

Total Valuation

DNLI has a market cap or net worth of $3.93 billion. The enterprise value is $2.63 billion.

Market Cap 3.93B
Enterprise Value 2.63B

Important Dates

The next estimated earnings date is Tuesday, November 5, 2024, after market close.

Earnings Date Nov 5, 2024
Ex-Dividend Date n/a

Share Statistics

DNLI has 143.17 million shares outstanding. The number of shares has increased by 12.10% in one year.

Shares Outstanding 143.17M
Shares Change (YoY) +12.10%
Shares Change (QoQ) +13.00%
Owned by Insiders (%) 4.65%
Owned by Institutions (%) 90.39%
Float 123.76M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS 160.42
PB Ratio 2.83
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 2,079.29
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 12.46, with a Debt / Equity ratio of 0.04.

Current Ratio 12.46
Quick Ratio 12.04
Debt / Equity 0.04
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -32.61% and return on invested capital (ROIC) is -23.11%.

Return on Equity (ROE) -32.61%
Return on Assets (ROA) -22.04%
Return on Capital (ROIC) -23.11%
Revenue Per Employee $2,847
Profits Per Employee -$943,043
Employee Count 445
Asset Turnover 0.00
Inventory Turnover n/a

Taxes

In the past 12 months, DNLI has paid $30,000 in taxes.

Income Tax 30,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +50.93% in the last 52 weeks. The beta is 1.38, so DNLI's price volatility has been higher than the market average.

Beta (5Y) 1.38
52-Week Price Change +50.93%
50-Day Moving Average 27.24
200-Day Moving Average 21.68
Relative Strength Index (RSI) 51.64
Average Volume (20 Days) 656,688

Short Selling Information

The latest short interest is 7.73 million, so 5.40% of the outstanding shares have been sold short.

Short Interest 7.73M
Short Previous Month 7.74M
Short % of Shares Out 5.40%
Short % of Float 6.25%
Short Ratio (days to cover) 8.86

Income Statement

In the last 12 months, DNLI had revenue of $1.27 million and -$419.65 million in losses. Loss per share was -$2.83.

Revenue 1.27M
Gross Profit -421.34M
Operating Income -495.21M
Pretax Income -419.62M
Net Income -419.65M
EBITDA -494.61M
EBIT -495.21M
Loss Per Share -$2.83
Full Income Statement

Balance Sheet

The company has $896.04 million in cash and $48.75 million in debt, giving a net cash position of $1.30 billion or $9.07 per share.

Cash & Cash Equivalents 896.04M
Total Debt 48.75M
Net Cash 1.30B
Net Cash Per Share $9.07
Equity (Book Value) 1.39B
Book Value Per Share 9.69
Working Capital 853.85M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$390.86 million and capital expenditures -$11.24 million, giving a free cash flow of -$402.10 million.

Operating Cash Flow -390.86M
Capital Expenditures -11.24M
Free Cash Flow -402.10M
FCF Per Share -$2.81
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -39,085.40%
Pretax Margin -33,119.49%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin -31,736.31%

Dividends & Yields

DNLI does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -12.10%
Shareholder Yield -12.10%
Earnings Yield -10.67%
FCF Yield -10.22%
Dividend Details

Analyst Forecast

The average price target for DNLI is $38.22, which is 39.13% higher than the current price. The consensus rating is "Strong Buy".

Price Target $38.22
Price Target Difference 39.13%
Analyst Consensus Strong Buy
Analyst Count 10
Revenue Growth Forecast (5Y) 16.76%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

DNLI has an Altman Z-Score of 13.39 and a Piotroski F-Score of 1.

Altman Z-Score 13.39
Piotroski F-Score 1